FDA Needs To Speed Up Full Approval Of COVID-19 Vaccines, Physician Says
The FDA could outline steps for full approval in a bid to be more transparent and to reassure those hesitant to get the vaccine, says Dr. Leana Wen of George Washington University.
The Food and Drug Administration's full approval of the coronavirus vaccines would go a long way toward convincing the vaccine hesitant to get the shot, says Dr. Leana Wen, an emergency physician and public health professor at George Washington University.
"But more importantly, I think it will convince some businesses that are currently on the fence about vaccine requirements to actually go that step and make the vaccines mandatory for employees," Wen says in a conversation with A Martínez on NPR's Morning Edition.
It's already well past the six-month mark for collecting enough safety data to determine if full approval should go ahead, she says.
Besides reassuring the public that vaccines are safe, full approval would allow pharmaceutical companies to do marketing. Doing so would help with public education, Wen notes.
The delay in fully greenlighting the vaccines has led to public confusion about the approval process, she says.
How to fix that? Outline the procedure, step by step, so that "people will know that it wasn't just politics driving this process."